Epigral Ltd (EPIGRAL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,035.00",
    "chg": 107.35,
    "chgp": "11.57%",
    "dir": 1,
    "prev_price": "927.65",
    "mcapval": "4,098.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE071N01016",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.63 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Epigral falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-epigral-fallingrising-3736297",
        "imagepath": "",
        "date": "2025-11-29 01:09:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Epigral's share price increase on 28-Nov outpaced its sector by 2.22%, signalling a short-term positive momentum. The stock has outperformed the Sensex over the past week, gaining 4.02% compared to the benchmark's 0.56%. However, this contrasts sharply with its one-month and year-to-date returns, which stand at -10.55% and -20.16% respectively, while the Sensex has posted gains of 1.27% and 9.68% over the same periods. Over the last year, the stock has declined by 26.82%, underperforming the Sensex's 8.43% rise. This divergence highlights the stock's recent resilience amid broader underperformance.</p>\n<p>Intraday, the stock reached a high of ₹1,517, trading above its five-day moving average but remaining below longer-term averages suc..."
      },
      {
        "title": "Epigral’s Market Assessment Revised Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3735129",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_mojoScore_3735129.png",
        "date": "2025-11-28 10:05:47",
        "description": "Epigral, a small-cap player in the specialty chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. Recent assessment changes highlight concerns across multiple analytical parameters, signalling a cautious outlook for investors."
      },
      {
        "title": "Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728809.png",
        "date": "2025-11-25 10:56:01",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market conditions that have weighed on the company’s valuation."
      },
      {
        "title": "Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728806.png",
        "date": "2025-11-25 10:56:01",
        "description": "Epigral, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant price level for the stock. This development comes amid a backdrop of varied financial indicators and market conditions that have influenced the stock's performance over the past year."
      },
      {
        "title": "Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728807",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728807.png",
        "date": "2025-11-25 10:55:58",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market dynamics that have weighed on the company’s valuation."
      },
      {
        "title": "Epigral Stock Hits 52-Week Low at Rs.1400 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728805",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728805.png",
        "date": "2025-11-25 10:55:54",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1400 today, marking a significant point in its recent market performance. This decline comes amid a broader context of subdued returns and financial metrics that reflect ongoing pressures on the company’s growth trajectory."
      },
      {
        "title": "Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728804.png",
        "date": "2025-11-25 10:55:52",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant milestone in its recent trading history. This decline reflects ongoing challenges in the company’s financial performance and market positioning, despite a broader market environment showing resilience."
      },
      {
        "title": "Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1400-amidst-continued-underperformance-3728802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3728802.png",
        "date": "2025-11-25 10:55:51",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a continuation of subdued market performance amid challenging financial indicators and sector dynamics."
      },
      {
        "title": "Epigral Stock Hits 52-Week Low at Rs.1428 Amid Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-stock-falls-to-52-week-low-of-rs1428-amidst-continued-underperformance-3725226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Epigral_priceRelatedfactors_3725226.png",
        "date": "2025-11-24 11:05:12",
        "description": "Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, marking a significant decline in its stock price amid broader market movements and sector-specific pressures."
      }
    ],
    "total": 551,
    "sid": "1003523",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Epigral Limited submit copy of Newspaper Publication pertaining to Un-Audited Financial Results - 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "31-Jan-2026",
      "details": "Epigral Limited submits Audio recording of Conference Call discussing Q3 FY26 Results.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "30-Jan-2026",
      "details": "Press Release on Un-Audited Financial Results - Q3 FY26.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>25%</strong> dividend, ex-date: 07 Feb 25",
          "dt": "2025-02-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Epigral falling/rising?

2025-11-29 01:09:13

Recent Price Movement and Market Context Epigral's share price increase on 28-Nov outpaced its sector by 2.22%, signalling a short-term positive momentum. The stock has outperformed the Sensex over the past week, gaining 4.02% compared to the benchmark's 0.56%. However, this contrasts sharply with its one-month and year-to-date returns, which stand at -10.55% and -20.16% respectively, while the Sensex has posted gains of 1.27% and 9.68% over the same periods. Over the last year, the stock has declined by 26.82%, underperforming the Sensex's 8.43% rise. This divergence highlights the stock's recent resilience amid broader underperformance. Intraday, the stock reached a high of ₹1,517, trading above its five-day moving average but remaining below longer-term averages suc...

Epigral’s Market Assessment Revised Amid Challenging Financial Trends

2025-11-28 10:05:47

Epigral, a small-cap player in the specialty chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. Recent assessment changes highlight concerns across multiple analytical parameters, signalling a cautious outlook for investors.

Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance

2025-11-25 10:56:01

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market conditions that have weighed on the company’s valuation.

Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Mixed Financial Signals

2025-11-25 10:56:01

Epigral, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant price level for the stock. This development comes amid a backdrop of varied financial indicators and market conditions that have influenced the stock's performance over the past year.

Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Challenging Market Conditions

2025-11-25 10:55:58

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a significant decline in its stock price over the past year. This development comes amid a backdrop of subdued financial performance and market dynamics that have weighed on the company’s valuation.

Epigral Stock Hits 52-Week Low at Rs.1400 Amidst Prolonged Downtrend

2025-11-25 10:55:54

Epigral, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.1400 today, marking a significant point in its recent market performance. This decline comes amid a broader context of subdued returns and financial metrics that reflect ongoing pressures on the company’s growth trajectory.

Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance

2025-11-25 10:55:52

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, marking a significant milestone in its recent trading history. This decline reflects ongoing challenges in the company’s financial performance and market positioning, despite a broader market environment showing resilience.

Epigral Stock Falls to 52-Week Low of Rs.1400 Amidst Prolonged Underperformance

2025-11-25 10:55:51

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1400, reflecting a continuation of subdued market performance amid challenging financial indicators and sector dynamics.

Epigral Stock Hits 52-Week Low at Rs.1428 Amid Sector Underperformance

2025-11-24 11:05:12

Epigral, a key player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.1428, marking a significant decline in its stock price amid broader market movements and sector-specific pressures.

View All News